Difference in the expression of IL-9 and IL-17 correlates with different histological pattern of vascular wall injury in giant cell arteritis

Rheumatology (United Kingdom)

Volumn 54, Issue 9, 2015, Pages 1596-1604

  Ciccia, Francesco ^a   Rizzo, Aroldo ^b   Guggino, Giuliana ^a   Cavazza, Alberto ^c   Alessandro, Riccardo ^a   Maugeri, Rosario ^a   Cannizzaro, Alessandra ^b   Boiardi, Luigi ^c   Iacopino, Domenico Gerardo ^a   Salvarani, Carlo ^c   Triolo, Giovanni ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Azienda Ospedaliera Ospedali Riuniti 'Villa Sofia Cervello'   (Italy)

^c S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

Giant cell arteritis; Small vessel vasculitis; Th17; Th9; Vasa vasorum vasculitis

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 8; INTERLEUKIN 9; INTERLEUKIN 9 RECEPTOR; PREDNISONE; THYMIC STROMAL LYMPHOPOIETIN; TRANSFORMING GROWTH FACTOR BETA; BIOLOGICAL MARKER; CYTOKINE; GLUCOCORTICOID;

ADULT; AGED; ARTICLE; BLOOD VESSEL BIOPSY; BLOOD VESSEL INJURY; CELL DIFFERENTIATION; CELL SURFACE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORRELATIONAL STUDY; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; GIANT CELL ARTERITIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NEUTROPHIL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYREXIA IDIOPATHICA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMALL VESSEL VASCULITIS; TASK PERFORMANCE; TEMPORAL ARTERY; TH9 CELL; TRANSMURAL INFLAMMATION; TREATMENT DURATION; VASA VASORUM; VASA VASORUM VASCULITIS; VASCULAR SMOOTH MUSCLE CELL; VASCULAR WALL INJURY; VASCULITIS; BIOPSY; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; PATHOLOGY; T LYMPHOCYTE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMARKERS; BIOPSY; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; GIANT CELL ARTERITIS; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-17; INTERLEUKIN-9; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; PHENOTYPE; PREDNISONE; T-LYMPHOCYTES; TEMPORAL ARTERIES; TRANSFORMING GROWTH FACTOR BETA; VASCULAR SYSTEM INJURIES;

EID: 84983121634     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kev102     Document Type: Article

References (18)

1. Salvarani C, Pipitone N, Versari A, Hunder GG. Clinical features of polymyalgia rheumatica and giant cell arteritis. Nat Rev Rheumatol 2012;8:509-21.
2. Restuccia G, Cavazza A, Boiardi L et al. Small-vessel vasculitis surrounding an uninflamed temporal artery and isolated vasa vasorum vasculitis of the temporal artery: two subsets of giant cell arteritis. Arthritis Rheum 2012;64: 549-56.
3. Esteban MJ, Font C, Hernández-Rodríguez J et al. Smallvessel vasculitis surrounding a spared temporal artery: clinical and pathological findings in a series of twentyeight patients. Arthritis Rheum 2001;44:1387-95.
4. Kaiser M, Younge B, Björnsson J, Goronzy JJ, Weyand CM. Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells. Am J Pathol 1999;155:765-74.
5. Deng J, Younge BR, Olshen RA, Goronzy JJ, Weyand CM. Th17 and Th1 T-cell responses in giant cell arteritis. Circulation 2010;121:906-15.
6. Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol 2010;28:445-89.
7. Weyand CM, Hicok KC, Hunder GG, Goronzy JJ. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med 1994;121:484-91.
8. Weyand CM, Tetzlaff N, Björnsson J et al. Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthritis Rheum 1997;40:19-26.
9. Ciccia F, Alessandro R, Rizzo A et al. IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis. Ann Rheum Dis 2012;72:258-64.
10. Blom L, Poulsen BC, Jensen BM, Hansen A, Poulsen LK. IL-33 induces IL-9 production in human CD4+ T cells and basophils. PLoS One 2011;6:e21695.
11. Kaplan MH. Th9 cells: differentiation and disease. Immunol Rev 2013;252:104-15.
12. Yao W, Zhang Y, Jabeen R et al. Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP. Immunity 2013;38:360-72.
13. Hernández-Rodríguez J, Segarra M, Vilardell C et al. Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism. Circulation 2003;107:2428-34.
14. Ciccia F, Alessandro R, Rizzo A et al. Expression of interleukin-32 in the inflamed arteries of patients with giant cell arteritis. Arthritis Rheum 2011;63:2097-104.
15. Abdelilah S, Latifa K, Esra N et al. Functional expression of IL-9 receptor by human neutrophils from asthmatic donors: role in IL-8 release. J Immunol 2001;166:2768-74.
16. Weyand CM, Goronzy JJ. Immune mechanisms in medium and large-vessel vasculitis. Nat Rev Rheumatol 2013;9:731-40.
17. Espígol-Frigolé G, Corbera-Bellalta M, Planas-Rigol E et al. Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis. Ann Rheum Dis 2013;72:1481-7.
18. Nadkarni S, Dalli J, Hollywood J et al. Investigational analysis reveals a potential role for neutrophils in giant-cell arteritis disease progression. Circ Res 2014;114:242-8.